Nextbiotix raises EUR7M series A round to bring IBD therapy into clinic

Microbiome company Nextbiotix S.A.S. (Dijon, France) raised €7 million ($8.1 million) in

Read the full 123 word article

How to gain access

Continue reading with a
two-week free trial.